Skip to main content
SpringerLink
Log in

Efficacia e sicurezza di Tirzepatide per il trattamento di soggetti affetti da obesità e sovrappeso

  • NOVITÀ IN ENDOCRINOLOGIA
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. World Obesity Federation (2022) World obesity atlas 2022. https://www.worldobesity.org/resources/resource-library/world-obesity-atlas-2022

    Google Scholar 

  2. Powell-Wiley TM, Poirier P, Burke LE et al. (2021) Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 143(21):e984–e1010

    Article  PubMed  PubMed Central  Google Scholar 

  3. Aronne LJ, Hall KD, Jakicic MJ et al. (2021) Describing the weight-reduced state: physiology, behavior, and interventions. Obesity 29(Suppl 1):S9–S24 (Silver Spring)

    PubMed  Google Scholar 

  4. Apovian CM, Aronne LJ, Bessesen DH et al. (2015) Pharmacological management of obesity: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100:342–362

    Article  CAS  PubMed  Google Scholar 

  5. Milluzzo A, Manuella L, Sciacca L (2022) Semaglutide: a game changer for metabolic diseases? Explor Med 3:173–180

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Medicina Clinica e Sperimentale, Sezione Endocrinologia, Università degli Studi di Catania, Catania, Italia

    Lucia Manuella & Laura Sciacca

Authors
  1. Lucia Manuella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Sciacca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura Sciacca.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Additional information

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Manuella, L., Sciacca, L. Efficacia e sicurezza di Tirzepatide per il trattamento di soggetti affetti da obesità e sovrappeso. L'Endocrinologo 24, 95–96 (2023). https://doi.org/10.1007/s40619-023-01221-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-023-01221-w

Search

Navigation